- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Surgery Partners Inc (SGRY)Surgery Partners Inc stock price live, this page displays NASDAQ SGRY stock exchange data. View the SGRY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Surgery Partners Inc real time stock price chart below.
What Is the Surgery Partners Inc Stock Price Today?
The Surgery Partners Inc stock price today is 23.84.
What Is the Stock Symbol for Surgery Partners Inc?
The stock symbol for Surgery Partners Inc is "SGRY."
What Stock Exchange Does Surgery Partners Inc Trade On?
Surgery Partners Inc is listed and trades on the NASDAQ stock exchange.
Is Surgery Partners Inc a Good Stock to Buy?
Determining whether Surgery Partners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGRY quote. (ISIN: US86881A1007)
What Is the Surgery Partners Inc Stock Price Today?
The Surgery Partners Inc stock price today is 23.84.
What Is the Stock Symbol for Surgery Partners Inc?
The stock symbol for Surgery Partners Inc is "SGRY."
What Stock Exchange Does Surgery Partners Inc Trade On?
Surgery Partners Inc is listed and trades on the NASDAQ stock exchange.
Is Surgery Partners Inc a Good Stock to Buy?
Determining whether Surgery Partners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGRY quote. (ISIN: US86881A1007)
23.84
+0.43(+1.84%)
Closed
Pre Market
23.62-0.22(-0.92%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.19
24.10
52 wk Range
21.36
36.92
SGRY Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.1924.10
52 wk Range
21.3636.92
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockSGRY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
36.29
Upside
+52.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
9 analysts have revised their earnings downwards for the upcoming period
Surgery Partners Inc Company Profile
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Surgery Partners Inc SWOT Analysis
Outpatient Shift | Surgery Partners capitalizes on the growing trend of high-acuity procedures moving to outpatient settings, positioning itself as a leader in cost-effective surgical care |
M&A Momentum | Explore Surgery Partners' aggressive acquisition strategy, outpacing expectations and potentially driving higher EBITDA outlook for the yea |
Strategic Options | Delve into the company's exploration of a potential sale, with reported interest from major players like TPG Inc. and UnitedHealth Group |
Financial Outlook | Analyst projections suggest steady growth, with EPS estimates ranging from $0.68 to $0.91 for FY2024 and $0.87 to $1.25 for FY2025 |
SGRY Full Pro Research
Institutional-Grade Stock Analysis
Understand how SGRY earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Surgery Partners Inc Earnings Call Summary for Q3/2024
- Q2 net revenue up 14.2% to $762M; adjusted EBITDA rose 18% to $118.3M with margins expanding 50 basis points
- Surgical case volume increased 4%; total joint cases in ASCs surged 46%
- Full-year outlook: net revenue >$3.075B, adjusted EBITDA >$508M; free cash flow guidance $140M-$160M
- $280M deployed for acquisitions and de novo investments; debt at $2.2B with no maturities until 2030
- Company aims to reduce leverage ratio below 3.0x; pursuing growth in total shoulder procedures for margin improvement
Last Updated: 07-08-2024, 06:44 pm
Read Full TranscriptCompare SGRY to Peers and Sector
Metrics to compare | SGRY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGRYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −49.7x | 9.7x | −0.7x | |
PEG Ratio | 0.77 | −0.11 | 0.00 | |
Price/Book | 1.6x | 1.4x | 2.6x | |
Price / LTM Sales | 1.0x | 0.7x | 3.2x | |
Upside (Analyst Target) | 46.8% | 20.4% | 44.5% | |
Fair Value Upside | Unlock | 3.7% | 6.6% | Unlock |
Analysts' Recommendations
9 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 36.29
(+52.24% Upside)
FAQ
What Is the Surgery Partners Inc (SGRY) Stock Price Today?
The Surgery Partners Inc stock price today is 23.84.
What Stock Exchange Does Surgery Partners Inc Trade On?
Surgery Partners Inc is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Surgery Partners Inc?
The stock symbol for Surgery Partners Inc is "SGRY."
What Is the Surgery Partners Inc Market Cap?
As of today, Surgery Partners Inc market cap is 3.01B.
What is Surgery Partners Inc Earnings Per Share?
The Surgery Partners Inc EPS is -0.481.
What Is the Next Surgery Partners Inc Earnings Date?
Surgery Partners Inc will release its next earnings report on 02 Mar 2025.
From a Technical Analysis Perspective, Is SGRY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.